NFKB1 and acute kidney injury: Moreover, the marked anti-inflammatory actions of linagliptin have been characterized in an endotoxin-induced acute kidney injury model [39], where DPP-4 inhibition inhibited NF-κB pathway and the downstream pro-inflammatory cytokines IL-1β and TNF-α.